Mexico
· Delayed Price · Currency is MXN Guardant Health Statistics
Total Valuation
Guardant Health has a market cap or net worth of MXN 97.64 billion. The enterprise value is 109.40 billion.
| Market Cap | 97.64B |
| Enterprise Value | 109.40B |
Important Dates
The next estimated earnings date is Friday, August 1, 2025.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 123.89M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.60% |
| Shares Change (QoQ) | +0.09% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 112.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.17 |
| PB Ratio | -19.05 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.85 |
| EV / Sales | 7.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -17.56 |
Financial Position
The company has a current ratio of 4.11
| Current Ratio | 4.11 |
| Quick Ratio | 3.61 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.29 |
| Interest Coverage | -166.70 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.64% |
| Return on Invested Capital (ROIC) | -22.99% |
| Return on Capital Employed (ROCE) | -40.64% |
| Revenue Per Employee | 7.87M |
| Profits Per Employee | -4.24M |
| Employee Count | 2,021 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 4.27 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +157.53% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +157.53% |
| 50-Day Moving Average | 1,333.61 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 51.51 |
| Average Volume (20 Days) | 1,682 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.23 |
Income Statement
In the last 12 months, Guardant Health had revenue of MXN 15.82 billion and -8.51 billion in losses. Loss per share was -69.06.
| Revenue | 15.82B |
| Gross Profit | 9.70B |
| Operating Income | -9.29B |
| Pretax Income | -8.49B |
| Net Income | -8.51B |
| EBITDA | -8.43B |
| EBIT | -9.29B |
| Loss Per Share | -69.06 |
Balance Sheet
The company has 14.28 billion in cash and 26.70 billion in debt, giving a net cash position of -12.42 billion.
| Cash & Cash Equivalents | 14.28B |
| Total Debt | 26.70B |
| Net Cash | -12.42B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -5.13B |
| Book Value Per Share | -41.46 |
| Working Capital | 14.33B |
Cash Flow
In the last 12 months, operating cash flow was -5.56 billion and capital expenditures -666.51 million, giving a free cash flow of -6.23 billion.
| Operating Cash Flow | -5.56B |
| Capital Expenditures | -666.51M |
| Free Cash Flow | -6.23B |
| FCF Per Share | n/a |
Margins
Gross margin is 61.34%, with operating and profit margins of -58.73% and -53.82%.
| Gross Margin | 61.34% |
| Operating Margin | -58.73% |
| Pretax Margin | -53.67% |
| Profit Margin | -53.82% |
| EBITDA Margin | -53.32% |
| EBIT Margin | -58.73% |
| FCF Margin | n/a |
Dividends & Yields
Guardant Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.60% |
| Shareholder Yield | -5.60% |
| Earnings Yield | -8.72% |
| FCF Yield | -6.38% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Guardant Health has an Altman Z-Score of -1.28. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.28 |
| Piotroski F-Score | n/a |